Zura Bio (ZURA) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Zura Bio Management to Meet With Cantor Fitzgerald
TipRanksOct 16 08:11 ET
Athanor Capital, LP Adjusts Stake in Zura Bio Ltd
Yahoo FinanceSep 23 15:05 ET
Institutions Profited After Zura Bio Limited's (NASDAQ:ZURA) Market Cap Rose US$45m Last Week but Private Equity Firms Profited the Most
Yahoo FinanceSep 20 09:27 ET
Zura Bio Is Maintained at Overweight by Piper Sandler
Dow JonesSep 19 12:40 ET · Ratings
Zura Bio Price Target Maintained With a $26.00/Share by Piper Sandler
Dow JonesSep 19 12:40 ET · Ratings
Zura Bio(ZURA.US) Director Sells US$10.26 Million in Common Stock
Moomoo NewsSep 13 16:19 ET

Comments

Trytosaveabit

Jun 14 05:04

Update

$Zura Bio (ZURA.US)$ Zura Bio Ltd: Tibulizumab (Zb-106) Was Well Tolerated and Neutralized Il-17a and Baff in a Phase 1 Study in Patients With Sjogren's Syndrome! Presents data at EULAR 2024

4

Drosen21

Jun 12 08:09

Hedgies may be confused over at Cantor…

$Zura Bio (ZURA.US)$ One is overweight and another to buy 🤫

1

Jaguar8

Jun 3 06:31

NEWS

$Zura Bio (ZURA.US)$
Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024
Zura Bio, a clinical-stage immunology company, announced its scheduled presentation at EULAR 2024 in Vienna from June 12-15. The company will unveil data on tibulizumab (ZB-106), a dual-pathway antibody targeting IL-17A and BAFF, focusing on its potential for treating Sjogren's syndrome and rheumatoid arthritis. The data aims to ...

1

Stock Region

May 6 05:44

Biotechnology Company Receives ''Overweight'' Rating From Investment Firm: 462% Upside

Zura Bio Garners Enthusiastic Ratings from Analysts with a Bright Outlook.
Zura Bio (NASDAQ:ZURA), Piper Sandler, a prestigious investment firm, has initiated coverage on the biotechnology company, assigning it an "overweight" rating and setting an ambitious price target of $26. This optimistic forecast suggests a potential upside of 462.77% from the stock's previous close. The announcement by Piper Sandler und...

1

Trytosaveabit

May 3 04:56

2 new 13G

$Zura Bio (ZURA.US)$ SC 13G: Statement of acquisition of beneficial ownership by individuals-Venrock Healthcare Capital Partners III, L.P.(9.99%),VHCP Co-Investment Holdings III, LLC(9.99%), etc.
SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(5.1%),Peter Kolchinsky(5.1%), etc.

1

ZURA Zura Bio

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target